| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2000 | EP0972200A1 Screening and treatment using complement regulator or receptor proteins |
| 01/19/2000 | EP0972198A1 Method for simultaneous detection of hiv antigens and hiv antibodies |
| 01/19/2000 | EP0972086A1 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property |
| 01/19/2000 | EP0972085A1 Sensors for electrically sensing binding events for supported molecular receptors |
| 01/19/2000 | EP0972084A2 Primers and methods for the detection of disseminated tumor cells |
| 01/19/2000 | EP0972082A1 Closed-loop biochemical analyzers |
| 01/19/2000 | EP0972081A1 Method of nucleic acid amplification |
| 01/19/2000 | EP0972079A1 A method to identify and breed corn with increased kernel oil concentration |
| 01/19/2000 | EP0972075A2 Methods for assessing cardiovascular status and compositions for use thereof |
| 01/19/2000 | EP0972074A1 A method for identifying the site of action of xenobiotic chemicals |
| 01/19/2000 | EP0972069A1 Production of functional proteins: balance of shear stress and gravity |
| 01/19/2000 | EP0972068A1 A process for synthesizing oligosaccharides |
| 01/19/2000 | EP0972064A1 Methods for producing retroviral vectors with an altered tropism |
| 01/19/2000 | EP0972063A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/19/2000 | EP0972062A2 Plant pest control |
| 01/19/2000 | EP0972061A2 Novel uses of male sterility in plants |
| 01/19/2000 | EP0972060A1 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 01/19/2000 | EP0972059A1 Nucleic acid molecules encoding starch phosphorylase from maize |
| 01/19/2000 | EP0972058A1 Method of hybrid seed production using conditional female sterility |
| 01/19/2000 | EP0972057A2 Method for screening antimycotically active substances |
| 01/19/2000 | EP0972056A1 Reagents and methods useful for detecting diseases of the lung |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972051A1 Rna-dependent rna polymerase functioning preferably on rna matrix and promoter-dependent transcription process with said rna-dependent rna polymerase |
| 01/19/2000 | EP0972050A1 Csk homologons kinaze (chk) for detecting and treating breast cancer |
| 01/19/2000 | EP0972049A1 Microbial production of 1,2-propanediol from sugar |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972046A1 METHODS OF PRODUCING AND USING VIRULENCE ATTENUATED $i(poxR) MUTANT BACTERIA |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972043A1 Human rantes mutants incapable of aggregate formation |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972039A1 Universal stem cells |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972037A2 $g(b)-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972035A1 Human tumor suppressor |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972031A1 Procollagen assembly |
| 01/19/2000 | EP0972030A2 70human secreted proteins |
| 01/19/2000 | EP0972029A1 Human secreted proteins |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
| 01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
| 01/19/2000 | EP0972022A2 Polynucleotides and polypeptides encoding receptors |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0972019A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer |
| 01/19/2000 | EP0972018A1 Non human transgenic animal in which the expression of the gene coding for insulin is deleted |
| 01/19/2000 | EP0972017A1 Efficient nuclear transfer using fetal fibroblasts |
| 01/19/2000 | EP0972016A1 A thermostable endo-beta-1,4-glucanase |
| 01/19/2000 | EP0972015A1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 01/19/2000 | EP0972013A1 Tissue specific promoters |
| 01/19/2000 | EP0972012A1 Immunosuppression |
| 01/19/2000 | EP0972011A1 Cyclin-dependent protein kinase |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971954A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971953A1 Vp22 proteins and uses thereof |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971951A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971946A1 Selection of proteins using rna-protein fusions |
| 01/19/2000 | EP0971944A1 Anti-viral guanosine-rich tetrad forming oligonucleotides |
| 01/19/2000 | EP0971736A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 01/19/2000 | EP0971734A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
| 01/19/2000 | EP0971731A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 01/19/2000 | EP0971730A2 Assay for ligands to tyrosine kinase receptors |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0971700A1 Identification of the progression elevated gene-3 and uses thereof |
| 01/19/2000 | EP0971693A2 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0971580A1 Regulatory element for expressing genes in plants |
| 01/19/2000 | EP0971579A1 Plant pathogen response gene |
| 01/19/2000 | EP0971578A1 Methods for $i(agrobacterium)-mediated transformation |
| 01/19/2000 | EP0955807A4 Dna and encoded protein which regulates cold and dehydration regulated genes |
| 01/19/2000 | EP0897392A4 Isolation and use of sh3 binding peptides |
| 01/19/2000 | EP0848616A4 Glucocorticoid enhancement of gene expression |
| 01/19/2000 | EP0841950A4 Neuronal progenitor cells and uses thereof |
| 01/19/2000 | EP0779921A4 CLONED SstI/SacI RESTRICTION-MODIFICATION SYSTEM |
| 01/19/2000 | EP0772631A4 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/19/2000 | EP0654086B1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | EP0587873B1 Process for the production of cells infected by a multiple sclerosis associated virus |
| 01/19/2000 | EP0563191B2 Nucleotide sequences of soybean acyl-acp thioesterase genes |
| 01/19/2000 | EP0552266B1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
| 01/19/2000 | EP0532587B1 Methods for trans-destabilization of specific proteins in vivo |
| 01/19/2000 | EP0515536B1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
| 01/19/2000 | CN1242054A Process and composition for preparing D-aspartic acid |